Innate Immune Mechanisms of Motor Neuron Injury
运动神经元损伤的先天免疫机制
基本信息
- 批准号:7860441
- 负责人:
- 金额:$ 21.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-05 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:Adaptor Signaling ProteinAdultAfferent NeuronsAgonistAmyotrophic Lateral SclerosisApoptosisApoptoticCause of DeathCell Culture TechniquesCell DeathCell SurvivalCellsCessation of lifeCleaved cellCoculture TechniquesDataDiseaseEquilibriumGenesGeneticGoalsHIVHealthHereditary Spastic ParaplegiaHornsImmuneInfectionInjuryKennedy SyndromeLigandsLinkMediatingMediator of activation proteinMetabolicModelingMolecularMotorMotor Neuron DiseaseMotor NeuronsMusMuscular AtrophyMutationNF-kappa BNeonatalNeurodegenerative DisordersNeurogliaNeuronsPathway interactionsPattern recognition receptorPoliomyelitisPoly I-CPopulationPrimary Lateral SclerosisProgressive Muscular AtrophyProteinsRNA VirusesRecruitment ActivityResearchSignal TransductionSpinal CordTLR3 geneTestingViralVirusVirus DiseasesWest Nile virusbasecaspase-3caspase-8cell injurycell typein vivoin vivo Modelisletmature animalmotor neuron degenerationmotor neuron injuryneurotropicpublic health relevancereceptor
项目摘要
DESCRIPTION (provided by applicant): Health Relatedness: A central question in neurodegenerative diseases is how specific populations of neurons undergo cell death. Selective degeneration of motor neurons occurs in the setting of diverse insults including RNA viruses such as HIV and West Nile, and in heritable mutations of ubiquitously expressed genes such as SOD1. It is unclear why proteins that are ubiquitously expressed, or why viruses that are not specifically neurotropic, should render motor neurons selectively vulnerable to death. The selective vulnerability of motor neurons may relate to their unique metabolic demands or, alternatively, they may possess a repertoire of proteins that contextually favor cell-death pathways. We have identified expression of TLR3, an innate immune pattern recognition receptor for duplex RNA, on multiple neuronal populations. While TLR3 is expressed in all neurons examined, activation on cortical neurons or sensory neurons has no effect on cell survival. By contrast, activation of TLR3 results in selective loss of motor neurons in primary dissociated spinal cord cultures. Administration of a TLR3 agonist in neonatal mice results in a loss of islet-1 positive neurons within the ventral horns. A clue into the cause of selective motor neuron death may be the observation that TLR3 recruits either cell-death activating or repressing proteins and we found its activation induces cleaved caspase-3 in motor neurons exclusively. Long-term goals: Our long-term goal is to define the function of TLR3 as a potential mediator of motor neuron death in translational models of motor neuron disease. Our hypothesis is that activation of the TLR3 pathway induces selective death in motor neurons as a consequence of their unique vulnerability. Research Approach: In aim 1, we will further investigate the selective vulnerability of motor neurons to TLR3 mediated death by expanding on our existing preliminary data and studying the cellular mechanisms involved. Different neuronal populations will be assessed for cell death following TLR3 activation in comparison to motor neurons. We will then determine if TLR3 functions autonomously in motor neurons to cause death or if TLR3 functions in an additional glial cell type to cause motor neuron death using glial- neuronal co-cultures. We will also determine if TLR3 functions in vivo, in both neonatal and adult animals, to induce selective death of motor neurons by comparing TLR3 knock-outs with strain matched controls. In aim 2 we will study the molecular basis by which TLR3 mediates selective death of motor neurons. We will determine if the proximal adaptor protein TRIF is necessary for TLR3 mediated death of motor neurons using cell culture and in vivo models. We will examine the essential branch points of TLR3 signaling to determine if the balance of NF-kB and caspase-8 activation favors cell death in motor neurons and cell survival in other neuronal types. Since both viral and native cellular ligands exist for TLR3, this pathway represents a new and unique link between infection, cell injury, and motor neuron disease. PUBLIC HEALTH RELEVANCE: Selective motor injury occurs in a number of neurodegenerative diseases such as Primary Lateral Sclerosis, pure Hereditary Spastic Paraplegia, Kennedy's disease, Spinal Muscular Atrophy, Progressive Muscular Atrophy, and amyotrophic lateral sclerosis, as well as in viral diseases such as Polio, HIV, and West Nile. Why specific populations of motor neurons are selectively vulnerable to the genetic and environmental conditions associated with these diseases is unknown. We have identified a receptor termed TLR3 present on all neurons, that when activated, induces death to only motor neurons. This application pursues research to define the relevance of this finding to diseases of the motor neuron.
描述(由申请人提供):健康相关性:神经退行性疾病的一个核心问题是特定神经元群体如何经历细胞死亡。运动神经元的选择性变性发生在各种损伤的环境中,包括RNA病毒如HIV和西尼罗河病毒,以及广泛表达的基因如SOD 1的遗传突变。目前还不清楚为什么普遍表达的蛋白质,或者为什么不是特异性嗜神经的病毒,应该使运动神经元选择性地容易死亡。运动神经元的选择性脆弱性可能与其独特的代谢需求有关,或者,它们可能拥有一系列有利于细胞死亡途径的蛋白质。我们已经确定了TLR 3的表达,先天免疫模式识别受体的双链RNA,在多个神经元群体。虽然TLR 3在所有检查的神经元中表达,但皮质神经元或感觉神经元的激活对细胞存活没有影响。相反,TLR 3的激活导致原代分离脊髓培养物中运动神经元的选择性丧失。在新生小鼠中施用TLR 3激动剂导致腹角内胰岛-1阳性神经元的损失。选择性运动神经元死亡的原因可能是观察到TLR 3招募细胞死亡激活或抑制蛋白,并且我们发现其激活仅在运动神经元中诱导切割的caspase-3。长期目标:我们的长期目标是确定TLR 3在运动神经元疾病转化模型中作为运动神经元死亡的潜在介导者的功能。我们的假设是,TLR 3通路的激活诱导运动神经元的选择性死亡,作为其独特的脆弱性的结果。研究方法:在目标1中,我们将通过扩展我们现有的初步数据和研究所涉及的细胞机制,进一步研究运动神经元对TLR 3介导的死亡的选择性脆弱性。与运动神经元相比,将评估不同神经元群体在TLR 3活化后的细胞死亡。然后,我们将使用神经胶质-神经元共培养物确定TLR 3是否在运动神经元中自主地起作用以引起死亡,或者TLR 3是否在另外的神经胶质细胞类型中起作用以引起运动神经元死亡。我们还将通过比较TLR 3敲除与菌株匹配的对照来确定TLR 3在新生动物和成年动物中是否在体内起作用以诱导运动神经元的选择性死亡。在目标2中,我们将研究TLR 3介导运动神经元选择性死亡的分子基础。我们将使用细胞培养和体内模型确定近端衔接蛋白TRIF是否是TLR 3介导的运动神经元死亡所必需的。我们将研究TLR 3信号传导的基本分支点,以确定NF-κ B和caspase-8激活的平衡是否有利于运动神经元的细胞死亡和其他神经元类型的细胞存活。由于TLR 3同时存在病毒和天然细胞配体,因此该途径代表了感染、细胞损伤和运动神经元疾病之间新的独特联系。公共卫生关系:选择性运动损伤发生在许多神经退行性疾病中,例如原发性侧索硬化症、纯遗传性痉挛性截瘫、肯尼迪病、脊髓性肌萎缩症、进行性肌萎缩症和肌萎缩性侧索硬化症,以及病毒性疾病,例如脊髓灰质炎、HIV和西尼罗河。为什么特定的运动神经元群体选择性地易受与这些疾病相关的遗传和环境条件的影响,目前尚不清楚。我们已经确定了一种名为TLR 3的受体存在于所有神经元上,当激活时,只会导致运动神经元死亡。本申请继续研究,以确定这一发现与运动神经元疾病的相关性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TIMOTHY VARTANIAN其他文献
TIMOTHY VARTANIAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TIMOTHY VARTANIAN', 18)}}的其他基金
Immune Privilege, CNS Autoimmunity, and Clostridium perfringens Epsilon Toxin
免疫特权、中枢神经系统自身免疫和产气荚膜梭菌 Epsilon 毒素
- 批准号:
10754021 - 财政年份:2023
- 资助金额:
$ 21.25万 - 项目类别:
Determining Enhanced Inflammatory B cell Function in African Americans with MS
确定患有多发性硬化症的非裔美国人中增强的炎症 B 细胞功能
- 批准号:
9896484 - 财政年份:2020
- 资助金额:
$ 21.25万 - 项目类别:
Determining Enhanced Inflammatory B cell Function in African Americans with MS
确定患有多发性硬化症的非裔美国人中增强的炎症 B 细胞功能
- 批准号:
10088395 - 财政年份:2020
- 资助金额:
$ 21.25万 - 项目类别:
Damage Associated Molecular Patterns and Regenerative Failure in MS
多发性硬化症中损伤相关的分子模式和再生失败
- 批准号:
10327692 - 财政年份:2017
- 资助金额:
$ 21.25万 - 项目类别:
Damage Associated Molecular Patterns and Regenerative Failure in MS
多发性硬化症中损伤相关的分子模式和再生失败
- 批准号:
10066376 - 财政年份:2017
- 资助金额:
$ 21.25万 - 项目类别:
Functional Link Between Innate Immunity, Oligodendrocyte Development, and Myelina
先天免疫、少突胶质细胞发育和髓鞘之间的功能联系
- 批准号:
7698962 - 财政年份:2009
- 资助金额:
$ 21.25万 - 项目类别:
Targeting innate immunity to prevent CNS injury in neonatal meningitis
针对先天免疫预防新生儿脑膜炎中枢神经系统损伤
- 批准号:
7133794 - 财政年份:2006
- 资助金额:
$ 21.25万 - 项目类别:
Targeting innate immunity to prevent CNS injury in neonatal meningitis
针对先天免疫预防新生儿脑膜炎中枢神经系统损伤
- 批准号:
7244141 - 财政年份:2006
- 资助金额:
$ 21.25万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 21.25万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 21.25万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 21.25万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 21.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 21.25万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 21.25万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 21.25万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 21.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 21.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 21.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)